Cryo-Electron Microscopy Test Market Size & Share 2026-2035

Cryo-Electron Microscopy Market Size

The global cryo-electron microscopy market was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.7 billion in 2026 to USD 4.3 billion by 2035, expanding at a CAGR of 10.6%, according to the latest report published by Global Market Insights Inc. The steady growth of the market is driven by the rising adoption in structure-based drug discovery and pharmaceutical R&D, expanding applications in virology and vaccine development and growing investments in structural biology research, among other factors.

The major players in the global market are Thermo Fisher Scientific, JEOL Ltd., Hitachi High-Tech, Gatan Inc. (AMETEK), and Carl Zeiss AG. These companies maintain their competitive position through ongoing product innovation, global market presence, and collaboration with pharmaceutical and biotechnology players, coupled with substantial investment in the market.

Cryo-electron microscopy (cryo-EM) has rapidly become a critical element of structure-based drug discovery by enabling scientists to visualize proteins, antibodies, and biomolecules at near-atomic resolution without crystallizing them. As a result, pharmaceutical companies can enhance their understanding of how diseases occur, define potential drug targets, and, in turn, develop and test their drug product candidates much more efficiently.

Additionally, cryo-EM provides exceptional capabilities for studying membrane proteins and exceedingly large complex biological structures, which is not easily possible through conventional analysis techniques. As pharmaceutical and biotechnology companies increase investments in precision medicine, biologics, and novel therapeutic approaches, demand for innovative imaging technologies is also growing significantly. Thus, the growing integration of cryo-EM into drug development workflows accelerates research timelines and supports market expansion.

The development of new technologies has enhanced the measurement and analysis capability of cryo-EM instruments through high-quality images, faster data acquisition, better resolution, and a range of other benefits. Improvements in automation may continue to lower operational barriers, allowing more researchers from universities and pharmaceutical companies to use cryo-EM. AI-driven methods for image reconstruction and image analysis will further assist in interpreting data and accelerate scientific progress. These innovations strengthen the value proposition of cryo-EM, encouraging upgrades of existing systems and new installations across diverse research environments.

Cryo-EM is an advanced imaging technique that enables the visualization of biological molecules, cells, viruses, and complex macromolecular structures at near-atomic resolution by rapidly freezing samples and preserving them in their native state.

Cryo-Electron Microscopy Market Trends

Rising importance in biologics and precision medicine development, growth of shared facilities and service-based access models, integration of artificial intelligence in data analysis, and expansion of automated and high-throughput workflows are among the key trends shaping the market growth in an upward trajectory.

• There is a significant rise in the number of researchers integrating machine learning and artificial intelligence into their cryo-EM workflows in order to speed up the processing of images and recreate the structure of new biomolecules. These technologies help researchers analyze massive datasets more efficiently, reduce processing times, improve image quality, and enhance the accuracy of biomolecular structure determination. Therefore, AI-enabled cryo-EM platforms are driving significant growth for laboratories as they prefer to achieve greater productivity while producing scientific results with a faster turnaround time.
• Additionally, due to the increased emphasis placed upon biologics, monoclonal antibodies (mAbs), gene therapy, and personalized medicine, researchers are now using cryo-electron microscopy more frequently than before. Researchers utilize the technique in order to obtain images of complex proteins and how they interact with each other so they may develop better therapies for patients. By using this technique, researchers can develop targeted therapies against disease and speed up the process of creating new therapies for patients.
• Further, due to the substantial capital investment required for cryo-EM installations, universities, research institutes, and commercial providers are increasingly offering shared-access facilities and specialized medical imaging services. This is creating a method for smaller research groups and newer biotech companies to use these high-end microscopy systems without the need to spend large amounts of capital on new equipment, which may help increase the use of this technology.

Cryo-Electron Microscopy Market Analysis

Based on product type, the market is segmented into instruments, software, services, and consumables and accessories. The instruments segment was valued at USD 928.4 million in 2025 and held a leading market share of around 61.1%.

• The instruments segment forms the core of the cryo-electron microscopy market and comprises transmission electron microscopes (TEM), scanning transmission electron microscopes (STEM), and cryo-scanning electron microscopes (cryo-SEM).
• TEM systems are extensively used for near-atomic-resolution structural analysis, while STEM instruments provide detailed imaging and analytical capabilities for nanoscale investigations. Cryo-SEM systems play an important role in examining the surface characteristics of frozen-hydrated samples while preserving their native morphology.
• Additionally, continuous improvements in detector technology, automation, imaging throughput, and computational integration are further enhancing instrument performance and encouraging upgrades across pharmaceutical companies, academic institutions, and research laboratories.
• The services segment accounted for USD 312.7 million in 2025 and is projected to grow at a robust CAGR over the forecast period. The services segment is an essential component of the cryo-electron microscopy market and includes fee-for-service access, instrument maintenance and repair, training services, and managed service contracts.
• In addition, the increased cost of owning equipment as well as the need for specialized knowledge to operate sophisticated systems contribute to the growing number of organizations choosing to outsource cryo-EM activities. Access to an advanced microscopy infrastructure through the use of service provider companies enables smaller research organizations and emerging biotech companies to benefit from using modern technologies without incurring the capital costs associated with them.
• Furthermore, training services help develop the specialized skills required for sample preparation, microscope operation, data acquisition, and image analysis, addressing the industry's need for qualified cryo-EM professionals.

Based on technology, the cryo-electron microscopy market is segmented into single particle analysis (SPA), cryo-electron tomography (cryo-ET), electron crystallography, and other technologies. The single particle analysis segment was valued at USD 837.6 million in 2025.

• Single particle analysis (SPA) is among the most frequently used cryo-EM techniques for finding high-resolution structures of proteins, macromolecular complexes, and biological assemblies. It involves taking thousands of images of single particles and using these to compute a high-resolution three-dimensional structure of the particles.
• Additionally, SPA has gained significant popularity because it eliminates the need for crystallization, which can be challenging for many biomolecules. SPA has very important uses in structural biology and pharmaceutical development, and the understanding of molecular interactions is very important.
• Advances in imaging hardware, computational algorithms, and automation have improved the accuracy and efficiency of SPA, making SPA a key tool when studying complex biological systems.
• The cryo-electron tomography segment accounted for USD 370.2 million in 2025 and is projected to grow at the highest CAGR over the forecast period. Cryo-electron tomography is an advanced imaging technique that allows researchers to visualize biological structures within their native cellular environments.
• By collecting images from multiple angles and reconstructing them into a three-dimensional model, cryo-ET provides detailed insights into cellular architecture and molecular organization. This technology is increasingly used to study viruses, organelles, protein complexes, and host-pathogen interactions.
• Further, growing interest in cellular biology, infectious disease research, and advanced therapeutic development is contributing to increased adoption of cryo-ET across research institutions worldwide.

Based on application, the cryo-electron microscopy market is segmented into structural biology, drug discovery and development, cancer research, vaccine research, cell and gene therapy, material science and nanotechnology, and other applications. The structural biology segment was valued at USD 426 million in 2025.

• Structural biology remains the leading application area for cryo-electron microscopy due to its ability to reveal the three-dimensional architecture of biomolecules at exceptional resolution. Researchers use cryo-EM to study proteins, nucleic acids, ribosomes, and molecular complexes that are essential for understanding biological functions and disease mechanisms.
• In addition, the technology provides critical information about molecular interactions and structural dynamics that cannot always be obtained through conventional imaging methods.
• Ongoing investments in life science research and advanced imaging infrastructure are further supporting the expansion of cryo-EM within structural biology applications.
• The drug discovery and development segment accounted for a 26.5% share in 2025 and is projected to grow at a notable CAGR over the forecast period. Cryo-EM has become an important tool in drug discovery and development by enabling researchers to visualize drug targets and molecular interactions with remarkable precision.
• The technology helps scientists understand protein structures, identify binding sites, and optimize therapeutic candidates during preclinical development.
• Additionally, the ability to generate detailed structural information accelerates decision-making and reduces uncertainties during the drug development process.
• The cancer research segment accounted for USD 165.3 million in 2025. Cancer research is emerging as a significant application area for cryo-EM because of the technology’s ability to investigate cancer-related proteins, signaling pathways, and molecular interactions.
• Researchers use cryo-EM to study the structural mechanisms underlying tumor development, disease progression, and treatment resistance.
• Further, detailed visualization of oncogenic proteins and biomolecular complexes helps scientists identify potential therapeutic targets and design more effective cancer treatments.

Based on end use, the cryo-electron microscopy market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and other end users. The pharmaceutical and biotechnology companies segment held a leading market share of 47.2% in 2025.

• Pharmaceutical and biotechnology companies are among the leading users of cryo-electron microscopy due to its value in drug discovery, biologics development, and molecular characterization. These organizations utilize cryo-EM to gain structural insights into proteins, antibodies, enzymes, and other therapeutic targets.
• Growing investments in precision medicine, gene therapies, and advanced biologics are further increasing demand for cryo-EM capabilities.
• Additionally, many companies are integrating the technology into core research workflows to accelerate development timelines, reduce research risks, and improve the likelihood of successful therapeutic outcomes.
• The academic and research institutes segment accounted for a 31.3% share in 2025. Academic and research institutes represent a key end-user segment because cryo-EM is widely used for fundamental scientific investigations and collaborative research projects.
• Universities and research centers employ the technology to explore molecular biology, cellular mechanisms, infectious diseases, and advanced materials.
• Further, access to high-resolution structural information enables researchers to address complex scientific questions and publish impactful findings. In addition, Government funding, institutional investments, and international research collaborations continue to expand cryo-EM infrastructure within academic settings.
• The contract research organizations segment accounted for USD 248 million in 2025. Contract research organizations are increasingly adopting cryo-EM to provide specialized structural analysis and research services to pharmaceutical, biotechnology, and academic clients.
• CROs offer access to advanced instrumentation, expert personnel, and comprehensive analytical capabilities, allowing clients to obtain high-quality cryo-EM data without major capital investments.
• Hence, the outsourcing trend in life sciences research has created strong demand for these services, particularly among small and mid-sized biotechnology companies.

North America Cryo-Electron Microscopy Market

The North America region accounted for 42.3% of the global market in 2025. The market is experiencing robust expansion, driven by the region’s advanced healthcare infrastructure, high R&D spending, presence of major pharma players, and technological advancements in devices.

• The U.S. market was valued at USD 425 million and USD 472.9 million in 2022 and 2023, respectively. In 2025 the market size increased to USD 607.1 million from USD 532.8 million in 2024.
• The U.S., in particular, has established numerous cryo-EM centers that support both academic and commercial research activities. Continuous technological innovation, widespread adoption of AI-enabled imaging tools, and strong collaboration between industry and research institutions are further accelerating market growth.
• North America represents a leading region in the market due to its strong concentration of pharmaceutical companies, biotechnology firms, academic research institutions, and government-funded scientific organizations.
• The increasing demand for biologics, gene therapies, and vaccine development is also encouraging the expansion of cryo-EM infrastructure and capabilities across North America.

Europe Cryo-Electron Microscopy Market

Europe market accounted for USD 406.8 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• Europe is experiencing significant growth in the market due to its well-developed life sciences ecosystem and strong emphasis on scientific research.
• Countries such as Germany, the UK, France, and the Netherlands have established advanced microscopy facilities that support structural biology, biomedical research, and pharmaceutical innovation.
• Additionally, collaborative research initiatives between universities, government organizations, and industry participants are driving the adoption of cryo-EM technologies.
• Furthermore, the presence of leading research networks and shared-access microscopy centers is improving technology accessibility and encouraging wider utilization of cryo-EM across academic and industrial applications.

Asia Pacific Cryo-Electron Microscopy Market

The Asia Pacific region is projected to show a lucrative growth of about 11.9% during the forecast period.

• Asia Pacific is emerging as the fastest-growing market for Cryo-Electron Microscopy, driven by expanding research infrastructure and rising investments in biotechnology and pharmaceutical development.
• Countries such as China, Japan, South Korea, India, and Australia are strengthening their scientific capabilities through the establishment of advanced imaging facilities and national research programs. In addition, increasing government support for life sciences research, growing healthcare expenditure, and the expansion of domestic pharmaceutical industries are contributing to technology adoption.
• Moreover, the region's growing focus on innovation, coupled with increasing participation in global scientific collaborations, is creating substantial opportunities for market expansion.

Latin America Cryo-Electron Microscopy Market

Latin America is experiencing significant growth in the market.

• The market in Latin America is growing steadily as scientific research capabilities continue to improve across the region.
• Brazil, Mexico, Argentina, and Chile are investing in research infrastructure to support advancements in biotechnology, healthcare, and life sciences. Universities and research institutions are gradually increasing access to advanced microscopy technologies through collaborative projects and shared research facilities.
• Furthermore, the region is also benefiting from growing interest in infectious disease research, agricultural biotechnology, and biomedical sciences.

Middle East and Africa Cryo-Electron Microscopy Market

• The Middle East and Africa market is witnessing gradual growth as governments and research organizations increase their focus on scientific innovation and healthcare development.
• Countries in the Gulf Cooperation Council (GCC), along with South Africa, are investing in advanced research infrastructure to strengthen capabilities in biotechnology, medical research, and pharmaceutical development.
• The establishment of research parks, academic partnerships, and national innovation programs is contributing to greater awareness and adoption of high-resolution imaging technologies.

Cryo-Electron Microscopy Market Share

The global cryo-electron microscopy (Cryo-EM) market is characterized by a relatively concentrated competitive environment, with a limited number of companies possessing the technological expertise, manufacturing capabilities, and research partnerships required to develop advanced cryo-EM systems. Competition is primarily centered on imaging resolution, automation capabilities, detector performance, software integration, workflow efficiency, and after-sales support.

Key companies operating in the market include Thermo Fisher Scientific, JEOL Ltd., Hitachi High-Tech, Gatan Inc. (AMETEK), and Carl Zeiss AG. Competition is expected to intensify as technological advancements, growing research investments, and expanding applications create opportunities for both established players and specialized technology providers.

In addition, leading market participants are focused on continuously improving microscope performance through innovations in electron optics, cryogenic sample handling, direct electron detectors, and artificial intelligence-enabled image analysis. Companies are also investing heavily in automated workflows that reduce operational complexity and increase throughput, enabling researchers to generate high-quality data more efficiently.

Further, strategic collaborations with pharmaceutical companies, biotechnology firms, universities, and research institutes have become a key competitive strategy. Such partnerships help manufacturers expand their installed base, strengthen product validation, and support the development of next-generation structural biology applications.

Cryo-Electron Microscopy Market Companies

Few of the prominent players operating in the cryo-electron microscopy industry include:

• Carl Zeiss AG
• Creative Biostructure
• Direct Electron LP
• Gatan Inc. (AMETEK)
• Hitachi High-Tech Corporation
• JEOL Ltd.
• Leica Microsystems GmbH
• Nanographics GmbH
• NanoImaging Services Inc.
• Oxford Instruments
• SPT Labtech Ltd.
• Structura Biotechnology Inc.
• TESCAN Group
• Thermo Fisher Scientific

• Thermo Fisher Scientific

Thermo Fisher Scientific focuses on expanding its cryo-EM leadership through continuous innovation in high-resolution microscopy platforms, integrated software ecosystems, workflow automation, and strategic collaborations with pharmaceutical companies and research institutions. The company also emphasizes comprehensive service support and application-specific solutions to strengthen customer retention and drive adoption.

• JEOL Ltd.

JEOL Ltd. pursues growth through the development of advanced electron microscopy systems featuring enhanced imaging performance, ease of operation, and analytical capabilities. The company emphasizes research partnerships, product customization, global distribution expansion, and technological innovation to address the evolving needs of life science and materials science researcher.

Cryo-Electron Microscopy Industry News

• In April 2026, Thermo Fisher Scientific introduced its Glacios 3 Cryo-TEM, a next-generation cryogenic transmission electron microscope designed to deliver high-performance 200 kV imaging. This development may enable the company to further expand its product portfolio and consolidate its position.
• In July 2023, JEOL installed two cryo-electron microscopes at Generate:Biomedicines to enable visualization of computationally designed molecules at very high scale. The installed devices produce terabytes of valuable data for researchers daily, who are accelerating drug discovery and the development of novel therapeutics using machine learning and generative artificial intelligence. This has enhanced the company's brand image in the key U.S. market.

The cryo-electron microscopy market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Instruments
  • Transmission electron microscopes (TEM)
  • Scanning transmission electron microscopes (STEM)
  • Cryo-scanning electron microscopes (cryo-SEM)
• Software
• Services
• Consumables and accessories

Market, By Technology

• Single particle analysis (SPA)
• Cryo-electron tomography (cryo-ET)
• Electron crystallography
• Other technologies

Market, By Application

• Structural biology
• Drug discovery and development
• Cancer research
• Vaccine research
• Cell and gene therapy
• Material science and nanotechnology
• Other applications

Market, By End Use

• Pharmaceutical and biotechnology companies
• Academic and research institutes
• Contract research organizations (CROs)
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE